The acquisition of Chinook is another win in Canada for San Francisco-based venture capital firm Versant Ventures, an early backer of BlueRock Therapeutics, which was acquired by Bayer AG for US$1-billion in 2019; Repare Therapeutics Inc., which went public in 2020; and Ventus Therapeutics Inc., which has raised US$300-million-plus and struck a development and licensing deal in 2022 with Novo Nordisk.